Hims & Hers Health is a top growth stock with strong cash flow, no debt, and an innovative AI-powered platform. Learn more on ...

SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and leader in data-driven medicine, has reached a historic milestone: more than two million patients genomic profiles analyzed on the AI ...

Sibel Health's journey from Northwestern spinout to FDA-cleared medtech innovator showcases Chicago's rising potential in ...

Medical technology company Sibel Health has secured $30m in an equity financing round to expedite the commercial deployment ...

Hims & Hers is shifting towards personalized medicine with AI-backed solutions. Find out why HIMS stock is buyable despite ...

It has been 5 years since the start of the COVID-19 pandemic, which forced many providers to embrace telehealth.In the fall ...

By incorporating healthspan science into clinical practice, some doctors are navigating a gray area between mainstream ...

Although cystic fibrosis is a single gene mutation, there are more than 1,000 different ways the CFTR gene can mutate in ...

Prime Editing has potential to be best-in-class approach for AATD -- -- Previously undisclosed program now emerging from within liver platform; leverages proprietary, universal liver LNP -- -- High ...

Even people who have been diagnosed don’t always spot inaccuracies or generalizations about the condition in the social media ...

Investigators said that the OLE study showed Roche’s gantenerumab dropped the risk of developing Alzheimer's symptoms by 50%.

Prime Medicine's program leverages the Company's universal liver lipid nanoparticle (LNP) to edit the E342K (Pi*Z) mutation in the SERPINA1 gene, the prevalent disease-causing mutation in AATD, ...